Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
For the last 2 decades, the progress in the clinical management of ENKTCL patients was based on Lasapraginase-containing combinations and the incorporation of radiation therapy into treatment algorithms. With increasing knowledge on lymphomagenesis, including genomiclandscape, and immunologic aspects of the disease, future developements will comprise more targeted approaches, including immune checkpoint inhibitors and novel antibodies.
…